Evidence map›Paper›PMID 39150957›Full record

ArticlePloS one2024

Optimization of culture condition for Spodoptera frugiperda by design of experiment approach and evaluation of its effect on the expression of hemagglutinin protein of influenza virus.

Fatemeh Alizadeh, Hamideh Aghajani, Fereidoun Mahboudi, Yeganeh Talebkhan, Ehsan Arefian, Sepideh Samavat, Rouhollah Raufi

Abstract readEvaluation Study
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatemeh AlizadehBiotechnology Research Center, Department of Medical Biotechnology, Pasteur Institute of Iran, Tehran, Iran.
Hamideh AghajaniDepartment of Research & Development, AryoGen Pharmed Inc., Karaj, Iran.
Fereidoun MahboudiBiotechnology Research Center, Department of Medical Biotechnology, Pasteur Institute of Iran, Tehran, Iran.
Yeganeh TalebkhanBiotechnology Research Center, Department of Medical Biotechnology, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0003-1988-4419
Ehsan ArefianMolecular Virology Lab, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Sepideh SamavatDepartment of Research & Development, AryoGen Pharmed Inc., Karaj, Iran.
Rouhollah RaufiDepartment of Research & Development, AryoGen Pharmed Inc., Karaj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The baculovirus expression vector system (BEVS) is a powerful tool in pharmaceutical biotechnology to infect insect cells and produce the recombinant proteins of interest. It has been well documented that optimizing the culture condition and its supplementation through designed experiments is critical for maximum protein production. In this study, besides physicochemical parameters including incubation temperature, cell count of infection, multiplicity of infection, and feeding percentage, potential supplementary factors such as cholesterol, polyamine, galactose, pluronic-F68, glucose, L-glutamine, and ZnSO4 were screened for Spodoptera frugiperda (Sf9) cell culture and expression of hemagglutinin (HA) protein of Influenza virus via Placket-Burman design and then optimized through Box-Behnken approach. The optimized conditions were then applied for scale-up culture and the expressed r-HA protein was characterized. Optimization of selected parameters via the Box-Behnken approach indicated that feed percentage, cell count, and multiplicity of infection are the main parameters affecting r-HA expression level and potency compared to the previously established culture condition. This study demonstrated the effectiveness of designing experiments to select and optimize important parameters that potentially affect Sf9 cell culture, r-HA expression, and its potency in the BEVS system.

Indexed as

Cell Culture TechniquesHemagglutininsOrthomyxoviridaeSpodopteraAnimalsCell LineGene ExpressionRecombinant ProteinsHemagglutininsRecombinant Proteins

Identifiers

PMID39150957
PMCPMC11329130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.